Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haemonetics Corp, Du PontfiledCriticalHaemonetics Corp
Publication of MY103370ApublicationCriticalpatent/MY103370A/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Abstract
A LYMPHOCYTE-CONTAINING WHITE BLOOD CELL FRACTION OBTAINED BY STANDARD LEUKAPHERESIS, ELUTRIATION LEUKAPHERESIS OR STANDARD CENTRIFUGATION CAN BE USED FOR PRODUCTION OF LYMPHOKINE ACTIVATED KILLER CELLS BY INCUBATION WITH IL-2. REMOVAL OF RED BLOOD CELLS AND GRANULOCYTES BY CENTRIFUGATION ON FICOLL IS NOT NECESSARY.
MYPI88000436A1988-04-271988-04-26A simplified method for the preparation of human lymphokine activated killer cells
MY103370A
(en)
Catalytic solid which can be used for the stereospecific polymerization of alpha-olefins, process for the preparation thereof and process for the polymerization of alpha-olefins in the presence thereof